RT Journal Article
SR Electronic
T1 Sars-Cov-2 in Argentina: Following Virus Spreading Using Granger Causality
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.10.06.20207993
DO 10.1101/2020.10.06.20207993
A1 Larrosa, Juan M.C.
YR 2020
UL http://medrxiv.org/content/early/2020/10/08/2020.10.06.20207993.abstract
AB There is a debate in Argentina on how COVID-19 outbreak in one district ends up infecting its neighbor districts. This contribution aims to use tools of time series analysis for understanding processes of contagious through regions. I use VAR and Granger causality for testing neighbor spreading via sequential rate of contagion. Results show that in the case of Argentina, contagion began in the capital city of Buenos Aires and then spread to its hinterland via specific districts. Once interior districts were infected a positive feedback dynamics emerge creating regions of high reproducibility of the virus where interventions may be focus in the very near future. This specific use of time series analysis may provide a tool for tracing infectiousness along regions that may help to anticipate infection and then for intervening for reducing the problems derived by the disease.Competing Interest StatementThe authors have declared no competing interest.Funding StatementI do not receive any funding for this dataset procurement.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:I hereby the right to post this manuscript and follows all relevant ethical guidelines.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data is available at DOI: 10.13140/RG.2.2.16398.18244 https://doi.org/10.13140/RG.2.2.16398.18244